News
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
A decade ago, a clinical trial in the U.K. famously showed that children who were exposed to peanuts in the early months of life had reduced risk of developing a peanut allergy compared with children ...
In 2019, Michael Rosenblum received an experimental new prostate cancer treatment after the disease spread to his bones. He remains symptom-free. The treatment is now approved for more patients.
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Margaret and her husband, David, were able to travel to Mexico because a clinical trial drug called zoldonrasib successfully controlled her lung cancer, which had returned after treatment. Dr. Kathryn ...
Find a researcher or lab Education & training programs MSK Innovation MSK Commercialization Ecosystem ...
Maureen Sideris, seated, with her sister Marion, receiving the 8th of 9 immunotherapy infusions during successful treatment for early-stage gastroesophageal junction cancer at Memorial Sloan Kettering ...
Jon Desjardins, far left, is happy to be around for his family, thanks to successful treatment with immunotherapy after surgery for colorectal cancer. He joined a clinical trial led by Dr. Yelena ...
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results